Patents by Inventor Pierre Belichard

Pierre Belichard has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITIONS AND METHODS FOR TREATING OPHTHALMIC DISORDERS
    Publication number: 20150368359
    Abstract: The present invention relates to compositions and methods for treating ophthalmic disorders of humans or animals. The present compositions and methods are highly suitable for intraocular administration into the interior of an eye and provide therapeutic effects to the eye as they are effective in stabilizing, enhancing and/or improving a patient's vision. More specifically, the present invention relates to compositions and methods for treating ophthalmic diseases or disorders with exudative, hemorrhagic and/or inflammatory conditions. Even more specifically, the present invention relates to compositions and methods for treating retinal diseases or disorders, and more specifically ophthalmic diseases or disorders related to impaired retinal vessel permeability and/or integrity.
    Type: Application
    Filed: June 19, 2015
    Publication date: December 24, 2015
    Applicant: Dyax Corp.
    Inventor: Pierre Belichard
  • Compositions and methods for treating ophthalmic disorders
    Patent number: 9107928
    Abstract: The present invention relates to compositions and methods for treating ophthalmic disorders of humans or animals. The present compositions and methods are highly suitable for intraocular administration into the interior of an eye and provide therapeutic effects to the eye as they are effective in stabilizing, enhancing and/or improving a patient's vision. More specifically, the present invention relates to compositions and methods for treating ophthalmic diseases or disorders with exudative, hemorrhagic and/or inflammatory conditions. Even more specifically, the present invention relates to compositions and methods for treating retinal diseases or disorders, and more specifically ophthalmic diseases or disorders related to impaired retinal vessel permeability and/or integrity.
    Type: Grant
    Filed: June 2, 2010
    Date of Patent: August 18, 2015
    Assignee: Dyax Corp.
    Inventor: Pierre Belichard
  • ARYLSULFONAMIDE DERIVATIVES FOR THE PREVENTION OR TREATMENT OF SPECIFIC OPHTHALMOLOGIC DISORDERS
    Publication number: 20130315903
    Abstract: The invention is directed to the therapeutic use of arylsulfonamide derivatives.
    Type: Application
    Filed: December 9, 2011
    Publication date: November 28, 2013
    Applicant: FOVEA PHARMACEUTICALS
    Inventors: Pierre Belichard, Didier Pruneau
  • COMPOSITIONS AND METHODS FOR TREATING OPHTHALMIC DISORDERS
    Publication number: 20100273721
    Abstract: The present invention relates to compositions and methods for treating ophthalmic disorders of humans or animals. The present compositions and methods are highly suitable for intraocular administration into the interior of an eye and provide therapeutic effects to the eye as they are effective in stabilizing, enhancing and/or improving a patient's vision. More specifically, the present invention relates to compositions and methods for treating ophthalmic diseases or disorders with exudative, hemorrhagic and/or inflammatory conditions. Even more specifically, the present invention relates to compositions and methods for treating retinal diseases or disorders, and more specifically ophthalmic diseases or disorders related to impaired retinal vessel permeability and/or integrity.
    Type: Application
    Filed: June 2, 2010
    Publication date: October 28, 2010
    Applicant: DYAX CORP.
    Inventor: PIERRE BELICHARD
  • TREATMENT OF NEOVASCULAR OCULAR DISEASE STATES
    Publication number: 20100233194
    Abstract: Compositions and regime or regimen for inhibiting unwanted ocular angiogenesis include the treatment of ocular neovascularization by administration of anti-angiogenesis agents, e.g., agents that inhibit VEGF, in combination with a second ocular therapy.
    Type: Application
    Filed: March 27, 2008
    Publication date: September 16, 2010
    Inventors: Jean-Philippe Combal, Elisabeth Latour, Pierre Belichard
  • Compositions and methods for treating ophthalmic disorders
    Publication number: 20070270344
    Abstract: The present invention relates to compositions and methods for treating ophthalmic disorders of humans or animals. The present compositions and methods are highly suitable for intraocular administration into the interior of an eye and provide therapeutic effects to the eye as they are effective in stabilizing, enhancing and/or improving a patient's vision. More specifically, the present invention relates to compositions and methods for treating ophthalmic diseases or disorders with exudative, hemorrhagic and/or inflammatory conditions. Even more specifically, the present invention relates to compositions and methods for treating retinal diseases or disorders, and more specifically ophthalmic diseases or disorders related to impaired retinal vessel permeability and/or integrity.
    Type: Application
    Filed: March 15, 2007
    Publication date: November 22, 2007
    Applicant: Fovea Pharmaceuticals
    Inventor: Pierre Belichard